What the study found
The study found that Russia's full-scale invasion caused major disruption to cancer care in Ukraine, affecting diagnosis, treatment, research, and palliative support. It also found that the oncology system showed strong resilience, with core services in government-controlled areas largely recovering to near pre-war levels by late summer 2022.
Why the authors say this matters
The authors conclude that Ukraine's experience shows complex cancer care can be sustained during prolonged conflict through coordinated governance, adaptive regulation, and international collaboration. They also say this offers a practical framework for rebuilding oncology and other non-communicable disease services in conflict-affected settings.
What the researchers tested
The article reviews how Ukraine's oncology system changed before and after the February 2022 invasion. It describes the effects of the war on care delivery, research, drug supply, telemedicine, workforce training, patient evacuation, and support from international and local organizations.
What worked and what didn't
Hospitals in combat zones shifted toward trauma care, while oncology facilities in safer areas were rapidly reorganized. By late summer 2022, drug supply and radiotherapy capacity had rebounded, clinical trials were being restored through decentralized and cross-border collaboration, and grassroots organizations were helping with patient navigation and advocacy. However, some patients still faced barriers linked to displacement, insecurity, and disrupted care pathways, and the recovery was described as fragile and uneven.
What to keep in mind
The summary does not provide detailed study methods or quantitative measures of recovery. It also notes that the recovery is still fragile and uneven, and that some barriers remain for patients in affected areas.
Key points
- Ukraine had a well-functioning oncology system before the February 2022 invasion, supported by universal health coverage.
- The war disrupted cancer diagnostics, treatment, research, and palliative support.
- Core cancer care in government-controlled territories had largely recovered to near pre-war levels by late summer 2022.
- International partners helped with drug supply, telemedicine, workforce training, and patient evacuation abroad.
- Clinical trials were initially halted and are being gradually restored.
- Grassroots and non-profit groups supported patient navigation, advocacy, psychological support, and palliative care.
Disclosure
- Research title:
- Wartime Ukraine cancer care largely recovered near pre-war levels
- Authors:
- Anna Karavska, Darya Kizub, Nataliya Kovalchuk, Serhii Brovchuk, Maryna Sokolovska, Andrei Nikiforchin, Nelya Melnitchouk
- Institutions:
- Brigham and Women's Hospital, Global Alliance for Rabies Control, Global Alliance for Rabies Control, Global Alliance for Rabies Control, Global Alliance for Rabies Control, Harvard University, Institute of Blood Pathology and Transfusion Medicine of the National Academy of Medical Sciences of Ukraine, Kyiv City Clinical Oncology Center, Kyiv City Clinical Oncology Center, National Cancer Institute, Stanford Medicine, Stanford University, The University of Texas MD Anderson Cancer Center
- Publication date:
- 2026-02-01
- OpenAlex record:
- View
Get the weekly research newsletter
Stay current with peer-reviewed research without reading academic papers — one filtered digest, every Friday.